Is HIV infection a risk factor for advanced cervical cancer?

被引:28
作者
Fruchter, RG [1 ]
Maiman, M [1 ]
Arrastia, CD [1 ]
Matthews, R [1 ]
Gates, EJ [1 ]
Holcomb, K [1 ]
机构
[1] SUNY Hlth Sci Ctr, Dept Obstet & Gynecol, Div Gynecol Oncol, Brooklyn, NY 11203 USA
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1998年 / 18卷 / 03期
关键词
HIV; risk factor; cervical cancer;
D O I
10.1097/00042560-199807010-00007
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objectives: To compare HIV-infected and HIV-negative women with invasive cervical cancer with respect to predictors of advanced disease. Methods: A retrospective analysis of 28 HIV-positive and 132 HIV-negative women with invasive cervical carcinoma was conducted and the two groups were compared with regard to stage of disease, demographic and behavioral variables, and risk factors for advanced disease. Results: Overall, HIV-infected women were more likely to have advanced disease, because 78% of HIV-positive women had Stage II to IV compared with 55% of HIV-negative women (odds ratio [OR] = 3.1; p = .03). Substance abuse was strongly associated with HIV infection, as were high-risk sexual variables. Although HIV infection was associated with a threefold increase in advance stage cervical cancer in a univariate analysis, only symptom duration and lack of a recent Papanicolaou smear were significant predictors of advanced disease in a multiple logistic regression analysis. Conclusions: The major predictors of advanced cervical cancer are similar in HIV-positive and HIV-negative women, although the reasons for these predictors may be very different. It is likely that a large proportion of HIV-positive patients with cervical cancer acquire HIV infection after initiation of the neoplastic process.
引用
收藏
页码:241 / 245
页数:5
相关论文
共 19 条
[1]  
BEARMAN DM, 1987, OBSTET GYNECOL, V69, P151
[2]  
BOYCE JG, 1990, OBSTET GYNECOL, V76, P627
[3]  
Fruchter R G, 1981, Cancer Detect Prev, V4, P481
[4]   CHARACTERISTICS OF CERVICAL INTRAEPITHELIAL NEOPLASIA IN WOMEN INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS [J].
FRUCHTER, RG ;
MAIMAN, M ;
SILLMAN, FH ;
CAMILIEN, L ;
WEBBER, CA ;
KIM, DS .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1994, 171 (02) :531-537
[5]   Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus [J].
Fruchter, RG ;
Maiman, M ;
Sedlis, A ;
Bartley, L ;
Camilien, L ;
Arrastia, CD .
OBSTETRICS AND GYNECOLOGY, 1996, 87 (03) :338-344
[6]   POPULATION-BASED STUDY OF MALIGNANCIES AND HIV-INFECTION AMONG INJECTING DRUG-USERS IN A NEW-YORK-CITY METHADONE TREATMENT PROGRAM, 1985-1991 [J].
GACHUPINGARCIA, A ;
SELWYN, PA ;
BUDNER, NS .
AIDS, 1992, 6 (08) :843-848
[7]  
Klevens RM, 1996, OBSTET GYNECOL, V88, P269
[8]   HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION AND CERVICAL NEOPLASIA [J].
MAIMAN, M ;
FRUCHTER, RG ;
SERUR, E ;
REMY, JC ;
FEUER, G ;
BOYCE, J .
GYNECOLOGIC ONCOLOGY, 1990, 38 (03) :377-382
[9]   Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus [J].
Maiman, M ;
Fruchter, RG ;
Sedlis, A ;
Feldman, J ;
Chen, P ;
Burk, RD ;
Minkoff, H .
GYNECOLOGIC ONCOLOGY, 1998, 68 (03) :233-239
[10]   Cervical cancer as an AIDS-defining illness [J].
Maiman, M ;
Fruchter, RG ;
Clark, M ;
Arrastia, CD ;
Matthews, R ;
Gates, EJ .
OBSTETRICS AND GYNECOLOGY, 1997, 89 (01) :76-80